GPC3 and cancer: In preclinical studies, shown to kill GPC3-positive cancer cell lines (Hep3B, HepG2, Huh 7) at picomolar doses. PBD dimer-based ADC is 5-10 times more effective than duocarmycin SA-based ADC [26].